India Panel Opposes Limiting Foreign Investment In Critical Drug Makers
This article was originally published in PharmAsia News
Executive Summary
India's Planning Commission and its Department of Industrial Policy & Promotion are at odds over the amount of foreign direct investment to be allowed in makers of drugs deemed critical to the country, now 100%.